combining retatrutide and tirzepatide The TRUTH About + (as a combo) #retatrutide #glp1weightloss Cagrilintide and Retatrutide for Men:

AOD-9604 is a synthetic fragment of the GH C-terminal peptide, comprising residues 177191 with an additional tyrosine at the N-terminus

Because of this, these peptides are now being studied for potential direct use in treating heart disease

A lower 4mg weekly dose also resulted in impressive weight loss results, with an average loss of 17% over 48 weeks and: 92% of participants lost at least 5% of their starting body weight 75% lost at least 10% of their body weight 60% lost at least 15% of their starting weight Retatrutide vs Mounjaro In clinical trials, the active ingredient in Mounjaro, tirzepatide, results in an average weight loss of 22.5% at the highest 15mg per week dose over 72 weeks

A.AwasthiS

Forest plot with P-score for biological and anthropometric outcomes